Necrotising enterocolitis in a newborn infant treated with octreotide for chylous effusion: is octreotide safe?

Octreotide is a somatostatin analogue used for treating congenital chylothorax and congenital hyperinsulinism in infants. By increasing splanchnic arteriolar resistance and decreasing gastrointestinal blood flow, octreotide indirectly reduces lymphatic flow in chylous effusions. Splanchnic ischaemia...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMJ Case Rep
Main Authors: Chandran, Suresh, Agarwal, Arpan, Llanora, Genevieve Villablanca, Chua, Mei Chien
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2020
Assuntos:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021135/
https://ncbi.nlm.nih.gov/pubmed/32051156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-232062
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares